ES515158A0 - Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. - Google Patents
Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.Info
- Publication number
- ES515158A0 ES515158A0 ES515158A ES515158A ES515158A0 ES 515158 A0 ES515158 A0 ES 515158A0 ES 515158 A ES515158 A ES 515158A ES 515158 A ES515158 A ES 515158A ES 515158 A0 ES515158 A0 ES 515158A0
- Authority
- ES
- Spain
- Prior art keywords
- heteroariltiazoles
- guanidino
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19623180A | 1980-10-14 | 1980-10-14 | |
US06/293,574 US4374843A (en) | 1980-10-14 | 1981-08-20 | 2-Guanidino-4-heteroarylthiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
ES515158A0 true ES515158A0 (es) | 1983-06-01 |
ES8306750A1 ES8306750A1 (es) | 1983-06-01 |
Family
ID=26891753
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES506216A Expired ES8301978A1 (es) | 1980-10-14 | 1981-10-13 | Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles. |
ES515158A Expired ES8306750A1 (es) | 1980-10-14 | 1982-08-20 | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. |
ES515159A Expired ES8306751A1 (es) | 1980-10-14 | 1982-08-20 | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. |
ES515157A Granted ES515157A0 (es) | 1980-10-14 | 1982-08-20 | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES506216A Expired ES8301978A1 (es) | 1980-10-14 | 1981-10-13 | Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES515159A Expired ES8306751A1 (es) | 1980-10-14 | 1982-08-20 | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. |
ES515157A Granted ES515157A0 (es) | 1980-10-14 | 1982-08-20 | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. |
Country Status (28)
Country | Link |
---|---|
US (1) | US4374843A (es) |
EP (1) | EP0050458B1 (es) |
KR (1) | KR850001858B1 (es) |
AR (3) | AR229703A1 (es) |
AT (1) | ATE11048T1 (es) |
AU (2) | AU530589B2 (es) |
CA (1) | CA1156239A (es) |
CS (1) | CS231182B2 (es) |
DD (4) | DD207719A5 (es) |
DE (1) | DE3168067D1 (es) |
DK (1) | DK453181A (es) |
ES (4) | ES8301978A1 (es) |
FI (1) | FI75821C (es) |
GR (1) | GR75098B (es) |
HK (1) | HK52387A (es) |
HU (2) | HU186788B (es) |
IE (1) | IE51642B1 (es) |
IL (1) | IL64035A (es) |
KE (1) | KE3707A (es) |
MY (1) | MY8700512A (es) |
NO (1) | NO159654C (es) |
NZ (1) | NZ198629A (es) |
PH (3) | PH17562A (es) |
PL (3) | PL133712B1 (es) |
PT (1) | PT73817B (es) |
SG (1) | SG23487G (es) |
SU (1) | SU1153829A3 (es) |
YU (4) | YU42434B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4482723A (en) * | 1983-04-11 | 1984-11-13 | Pfizer Inc. | Process for preparation of 4-acetyl-2-substituted-imidazoles |
US4435396A (en) | 1982-05-10 | 1984-03-06 | Pfizer Inc. | Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor |
GB2122988B (en) * | 1982-06-17 | 1986-06-11 | Toyama Chemical Co Ltd | Process for producing 2-(2-aminothiazol-4-yl) glyoxylic acid derivative; intermediates |
EP0156644A1 (en) * | 1984-04-02 | 1985-10-02 | Pfizer Inc. | Process and intermediates for 4-acetylimidazoles |
US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
US4632993A (en) * | 1984-10-11 | 1986-12-30 | Pfizer Inc. | Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide |
US4591595A (en) * | 1984-10-11 | 1986-05-27 | Pfizer Inc. | 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis |
US4567179A (en) * | 1984-10-11 | 1986-01-28 | Pfizer, Inc. | Antiinflammatory salts of piroxicam |
WO1986003203A1 (en) * | 1984-11-22 | 1986-06-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienylthiazole derivatives |
US4814341A (en) * | 1986-08-26 | 1989-03-21 | Reiter Lawrence A | 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents |
ATE66477T1 (de) * | 1986-08-29 | 1991-09-15 | Pfizer | 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren. |
DE3750023T2 (de) * | 1986-10-29 | 1994-09-29 | Pfizer, Inc., New York, N.Y. | Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat. |
IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
CA2105981A1 (en) * | 1991-03-13 | 1992-09-14 | Hisashi Takasugi | Thiazole derivatives |
SI0928793T1 (en) * | 1998-01-02 | 2002-10-31 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
KR20080039979A (ko) * | 2005-08-23 | 2008-05-07 | 우베 고산 가부시키가이샤 | 1-치환-5-아실이미다졸 화합물의 제법 |
US9499533B2 (en) | 2012-03-27 | 2016-11-22 | Shionogi & Co., Ltd. | Aromatic 5-membered heterocyclic derivative having TRPV4-Inhibiting activity |
US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1516777A (fr) * | 1966-08-02 | 1968-02-05 | Innothera Lab Sa | Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation |
US3519637A (en) * | 1966-12-06 | 1970-07-07 | Hoffmann La Roche | 1-(4-thiazolylmethyl)nitroimidazole derivatives |
BE758146A (fr) * | 1969-10-29 | 1971-04-28 | Smith Kline French Lab | Derives de l'amidine |
US3950353A (en) * | 1971-03-09 | 1976-04-13 | Smith Kline & French Laboratories Limited | Pharmacologically active thiourea and urea compounds |
HU168776B (es) * | 1973-11-09 | 1976-07-28 | ||
DE2614189A1 (de) * | 1976-04-02 | 1977-10-20 | Hoechst Ag | Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung |
ZA782129B (en) * | 1977-04-20 | 1979-03-28 | Ici Ltd | Hertocyclic derivatives |
DE2961923D1 (en) * | 1978-01-18 | 1982-03-11 | Ici Plc | Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them |
EP0014057B1 (en) * | 1979-01-18 | 1985-01-02 | Imperial Chemical Industries Plc | Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them |
US4220654A (en) * | 1979-06-04 | 1980-09-02 | Merck & Co., Inc. | Cyclic imidazole cyanoguanidines |
AU518569B2 (en) * | 1979-08-07 | 1981-10-08 | Farmos-Yhtyma Oy | 4-benzyl- and 4-benzoyl imidazole derivatives |
-
1981
- 1981-08-20 US US06/293,574 patent/US4374843A/en not_active Expired - Fee Related
- 1981-10-12 DE DE8181304724T patent/DE3168067D1/de not_active Expired
- 1981-10-12 EP EP81304724A patent/EP0050458B1/en not_active Expired
- 1981-10-12 IE IE2384/81A patent/IE51642B1/en unknown
- 1981-10-12 IL IL64035A patent/IL64035A/xx unknown
- 1981-10-12 AT AT81304724T patent/ATE11048T1/de not_active IP Right Cessation
- 1981-10-13 ES ES506216A patent/ES8301978A1/es not_active Expired
- 1981-10-13 HU HU812951A patent/HU186788B/hu not_active IP Right Cessation
- 1981-10-13 CA CA000387744A patent/CA1156239A/en not_active Expired
- 1981-10-13 HU HU833918A patent/HU191895B/hu not_active IP Right Cessation
- 1981-10-13 YU YU2464/81A patent/YU42434B/xx unknown
- 1981-10-13 KR KR1019810003857A patent/KR850001858B1/ko active
- 1981-10-13 NZ NZ198629A patent/NZ198629A/en unknown
- 1981-10-13 AU AU76287/81A patent/AU530589B2/en not_active Ceased
- 1981-10-13 NO NO813442A patent/NO159654C/no unknown
- 1981-10-13 CS CS817500A patent/CS231182B2/cs unknown
- 1981-10-13 PH PH26341A patent/PH17562A/en unknown
- 1981-10-13 SU SU813344744A patent/SU1153829A3/ru active
- 1981-10-13 FI FI813177A patent/FI75821C/fi not_active IP Right Cessation
- 1981-10-13 DK DK453181A patent/DK453181A/da not_active Application Discontinuation
- 1981-10-13 GR GR66268A patent/GR75098B/el unknown
- 1981-10-14 DD DD81248821A patent/DD207719A5/de not_active IP Right Cessation
- 1981-10-14 PT PT73817A patent/PT73817B/pt unknown
- 1981-10-14 PL PL1981241643A patent/PL133712B1/pl unknown
- 1981-10-14 PL PL1981233430A patent/PL134491B1/pl unknown
- 1981-10-14 DD DD81248822A patent/DD207913A5/de not_active IP Right Cessation
- 1981-10-14 DD DD81234080A patent/DD202293A5/de not_active IP Right Cessation
- 1981-10-14 PL PL1981241644A patent/PL135331B1/pl unknown
- 1981-10-14 DD DD81248820A patent/DD207718A5/de not_active IP Right Cessation
-
1982
- 1982-08-20 ES ES515158A patent/ES8306750A1/es not_active Expired
- 1982-08-20 ES ES515159A patent/ES8306751A1/es not_active Expired
- 1982-08-20 ES ES515157A patent/ES515157A0/es active Granted
- 1982-08-27 AR AR290461A patent/AR229703A1/es active
- 1982-08-27 AR AR290462A patent/AR228674A1/es active
- 1982-08-27 AR AR290463A patent/AR228675A1/es active
-
1983
- 1983-04-06 PH PH28741A patent/PH17856A/en unknown
- 1983-04-06 PH PH28740A patent/PH18467A/en unknown
- 1983-05-12 YU YU1052/83A patent/YU42077B/xx unknown
- 1983-05-12 YU YU1051/83A patent/YU42076B/xx unknown
- 1983-05-12 YU YU1053/83A patent/YU42078B/xx unknown
-
1984
- 1984-08-17 AU AU32062/84A patent/AU548992B2/en not_active Ceased
-
1987
- 1987-03-09 SG SG234/87A patent/SG23487G/en unknown
- 1987-03-20 KE KE3707A patent/KE3707A/xx unknown
- 1987-07-09 HK HK523/87A patent/HK52387A/xx unknown
- 1987-12-30 MY MY512/87A patent/MY8700512A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES506969A0 (es) | Un procedimiento para la preparacion de pirimidinas sustitu-idas. | |
ES501645A0 (es) | Un procedimiento para la preparacion de 6-alquiliden-penamas. | |
ES508286A0 (es) | Un procedimiento para la preparacion de derivados de imidazolil-propanol. | |
ES507298A0 (es) | Un procedimiento para la preparacion de derivados de 2-feniletanolamina. | |
ES505464A0 (es) | Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas. | |
ES519057A0 (es) | Un procedimiento para la preparacion de derivados de caprolactama. | |
ES507501A0 (es) | Un procedimiento para la preparacion de imidazolilfenilamidinas. | |
ES503307A0 (es) | Un procedimiento para la preparacion de quinoxaliniloxieteres. | |
ES515159A0 (es) | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. | |
ES505922A0 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalospirina. | |
ES509312A0 (es) | Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona. | |
ES507755A0 (es) | Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida. | |
ES501339A0 (es) | Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno. | |
ES504790A0 (es) | Un procedimiento para la preparacion de derivados de enantolactama. | |
ES502153A0 (es) | Un procedimiento para la preparacion de compuestos n-acil-n- (cicloalquil) aminoacidos. | |
ES504793A0 (es) | Un procedimiento para la preparacion de nuevos derivados de caprilolactama. | |
ES507918A0 (es) | Un procedimiento para la preparacion de benzamitas sustituidas. | |
ES503338A0 (es) | Un procedimiento para la preparacion de derivados de bis-hidroxibencilo. | |
ES505920A0 (es) | Un procedimiento para la preparacion de derivados de isonicotinanilida. | |
ES504577A0 (es) | Un procedimiento para la preparacion de derivados de piridazinona. | |
ES507482A0 (es) | Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina. | |
ES507919A0 (es) | Un procedimiento para la preparacion de benzopiranotriazoles antialergicos. | |
ES500870A0 (es) | Un procedimiento para la preparacion de nuevos derivados de triariltiazol. | |
ES507045A0 (es) | Un procedimientpo para la preparacion de nuevos derivados de carbamoiloxiisoxazol. | |
ES514335A0 (es) | Un procedimiento para la preparacion de guanidinas. |